Clinical Trials
3
Active:1
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 1
1 (33.3%)Phase 4
1 (33.3%)LIPT - Liraglutide in Polycystic Ovary Syndrome
Phase 4
Completed
- Conditions
- Polycystic Ovary SyndromeCardiovascular Disease
- Interventions
- Drug: placebo
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- Jens Faber
- Target Recruit Count
- 72
- Registration Number
- NCT02073929
- Locations
- 🇩🇰
Dept. of Medicine and Dept. of Gyn-Obs, Herlev Hospital, Herlev, Denmark
🇩🇰Herlev Hospital, Dept of Gynecology, Herlev, Denmark
🇩🇰Dept. of Medicine and Dept. of Obstetrics and Gynaecology, Herlev Hospital, Herlev, Denmark
Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)
- First Posted Date
- 2011-11-29
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Jens Faber
- Target Recruit Count
- 21
- Registration Number
- NCT01481402
- Locations
- 🇩🇰
Herlev Hospital, Dept. of Endocrinology, Herlev, Denmark
News
No news found